US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hematopoietic Cell Proliferation
- Sickle Cell Disease
- Umbilical Cord Blood
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 5 years and 30 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04594031
- Collaborators
- California Institute for Regenerative Medicine (CIRM)
- Investigators
- Study Director: Medical Monitor ExCellThera inc.